Skip to main content
UNITED THERAPEUTICS Corp logo

UNITED THERAPEUTICS Corp — Investor Relations & Filings

Ticker · UTHR ISIN · US91307C1027 LEI · 5299005C4HZL4UWROC14 US Manufacturing
Open in API
Filings indexed 2,877 across all filing types
Latest filing 2025-12-19 Director's Dealing
Country US United States of America
Listing US UTHR

About UNITED THERAPEUTICS Corp

https://www.unither.com/

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of therapies for chronic and life-threatening conditions. The company's primary therapeutic areas include pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also develops treatments for pediatric neuroblastoma. In addition to its pharmaceutical pipeline, United Therapeutics is actively engaged in research and development of technologies to manufacture transplantable organs and tissues, aiming to address the shortage of donor organs.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2025-12-19 English
PRIMARY DOCUMENT
Director's Dealing
2025-12-19 English
Regulatory Filings 2025
Regulatory Filings
2025-12-18 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document text contains multiple entries of share transactions by Martine Rothblatt, the founder, chairperson, and CEO of United Therapeutics Corp. The entries detail dates, number of shares, and prices, indicating personal share transactions. There is no indication of financial results, report publication, or other types of filings. The presence of detailed insider share transactions aligns with the definition of Director's Dealing filings, which report personal share transactions by company directors and executives. The document length is 6379 characters, sufficient to contain detailed transaction data. Therefore, the document is best classified as a Director's Dealing report.
2025-12-18 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document text contains detailed records of share transactions by Martine Rothblatt, the founder, chairperson, and CEO of United Therapeutics Corp. It lists multiple dates, share quantities, and transaction details related to shares exercised via vested options and payments made via common shares. This type of information corresponds to insider trading or personal share transactions by company directors or executives. There is no indication of financial statements, earnings data, or report announcements. The document length is about 6,379 characters, which is sufficient to contain detailed transaction data. Therefore, the document fits the definition of a Director's Dealing report.
2025-12-17 English
PRIMARY DOCUMENT
Director's Dealing
2025-12-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.